We provide flexible solutions
adapted to industrial realism
What we do?
For over twenty years, Aptys pharma® has been actively involved in the galenic formulation and design of medicines. This solid experience has led us to develop our own products for licensing or sale.
A unique and
Discover our know-how
Aptys pharma® is a research and development company. We implement technologies to formulate or reformulate molecules. Our pharmaceutical and biotechnology expertise enables us to support our clients in the design and formulation, analytical development, and quality control of medicines.
a major challenge
What is our commitment to pain management?
Aptys pharma® has been involved with several partners for more than 15 years in the fight against pain by developing an alternative to opiates.
An ongoing challenge
driven by passion
Our ambition has always been to design and develop innovative medicines thanks to our proven know-how. Our galenic formulation patents are the synthesis of academic and industrial experience in the field of peptide-based medicines.
Aptys pharma® has developed many high-tech products under contract or for its own account, with the aim of selling the product once at an advanced stage of development.
- Formulation design laboratory
- Analytical laboratory
- Preformulation analysis using SoluDiag® and NanoSolution® technology that are two fast and low raw material usage methods.
- Formulation of immediate and controlled release tablets, microspheres, microcapsules, gels, creams, solutions, and suspensions.
- Analytical development, validation, quality control and stability testing.
Welcome to the strategic committee
Aptys Pharma is pleased to welcome Cécile Thébault to its strategic committee.Read more
Welcome to the executive committee
We are pleased to welcome Jérôme Martinez as a new member of APTYS PHARMA’s Executive Committee.Read more
New opportunities at BIOFIT 2022
With more than 900 attendees, 35 countries represented and 80 exhibitors, BIOFIT is an essential event in terms of business development for APTYS PHARMA.Read more